Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance

doi:10.3748/wjg.v17.i16.2113

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3856)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

407

HTML

3131

Figures (1-4)

179

Tables (1-4)

139

Sum=3856

Apr 28, 2011 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 28, 2011; 17(16): 2113-2119
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2113

Table 2 Antitumor response of 23 Taiwanese with advanced gastrointestinal stromal tumor treated with sunitinib

	n (%)	Sunitinib duration (median, mo)	TTR/TTP (median, mo)	OS (median, mo)
CR	2 (8.7)	9.85	3.73/NA	NA
PR	4 (17.4)	12.3	3.67/12.71	NA
SD	9 (39.1)	11.9	1.87/13.53	14.03
PD	8 (34.8)	3.63	2.37	NA

CR: Complete response; PR: Partial response; SD: Stationary disease; PD: Progression of disease; TTR: Time to response; TTP: Time to progression; OS: Overall survival.

Citation: Chen YY, Yeh CN, Cheng CT, Chen TW, Rau KM, Jan YY, Chen MF. Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance. World J Gastroenterol 2011; 17(16): 2113-2119
URL: https://www.wjgnet.com/1007-9327/full/v17/i16/2113.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i16.2113